Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-20

Clinical Trial Update: Effects of EPA on Prostate Cancer Cells Proliferation and Quality of Life [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effects of eicosapentaenoic acid (EPA) on prostate cancer cell proliferation and patient quality of life; currently not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eicosapentaenoic acid (EPA) (eicosapentaenoic acid)

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING